Role of macrophages in pulmonary arterial hypertension

Role of macrophages in pulmonary arterial hypertension

Pulmonary arterial hypertension (PAH) is a severe cardiopulmonary vascular disease characterized by progressive pulmonary artery pressure elevation, increased pulmonary vascular resistance and ultimately right heart failure. Studies have demonstrated the involvement of multiple immune cells in the d...

Full description

Bibliographic Details
Main Authors:	Meng-Qi Zhang, Chen-Chen Wang, Xiao-Bin Pang, Jun-Zhuo Shi, Hao-Ran Li, Xin-Mei Xie, Zhe Wang, Hong-Da Zhang, Yun-Feng Zhou, Ji-Wang Chen, Zhi-Yan Han, Lu-Ling Zhao, Yang-Yang He
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-04-01
Series:	Frontiers in Immunology
Subjects:	Pulmonary arterial hypertension macrophages inflammatory response vascular remodeling macrophage microenvironment
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1152881/full

Similar Items

Single cell transcriptomic analyses reveal diverse and dynamic changes of distinct populations of lung interstitial macrophages in hypoxia-induced pulmonary hypertension
by: Sushil Kumar, et al.
Published: (2024-04-01)

Perivascular Inflammation in Pulmonary Arterial Hypertension
by: Yijie Hu, et al.
Published: (2020-10-01)

Effect of overexpression of microRNA-124 on pulmonary vascular remodeling in rats with pulmonary arterial hypertension
by: Zhu Jian, Chen Tiantian, Liu Zhiyong, Zheng Changlong
Published: (2023-08-01)

Inactivating the Uninhibited: The Tale of Activins and Inhibins in Pulmonary Arterial Hypertension
by: Gusty Rizky Teguh Ryanto, et al.
Published: (2023-02-01)

The effect of transglutaminase-2 inhibitor on pulmonary vascular remodeling in rats with pulmonary arterial hypertension
by: Ting Wang, et al.
Published: (2022-02-01)

Pulmonary Vascular Remodeling in Pulmonary Hypertension
by: Zhuangzhuang Jia, et al.
Published: (2023-02-01)

Impact of Parenteral Prostanoids in Pulmonary Arterial Hypertension: The Relevance of Timing
by: Silvia Papa, et al.
Published: (2023-10-01)

Novel insights and new therapeutic potentials for macrophages in pulmonary hypertension
by: Yifan Zuo, et al.
Published: (2024-03-01)

Editorial: Advances in understanding the mechanisms of pulmonary hypertension
by: Ashfaq Ahmad, et al.
Published: (2023-09-01)

Endothelial Autocrine Signaling through CXCL12/CXCR4/FoxM1 Axis Contributes to Severe Pulmonary Arterial Hypertension
by: Dan Yi, et al.
Published: (2021-03-01)

Adipokines in pulmonary hypertension: angels or demons?
by: Qi Jia, et al.
Published: (2023-11-01)

Ginaton reduces M1-polarized macrophages in hypertensive cardiac remodeling via NF-κB signaling
by: Jie Wang, et al.
Published: (2023-03-01)

RGS5 as a Biomarker of Pericytes, Involvement in Vascular Remodeling and Pulmonary Arterial Hypertension
by: Lu G, et al.
Published: (2023-10-01)

Natural Products for the Treatment of Pulmonary Hypertension: Mechanism, Progress, and Future Opportunities
by: Zuomei Zeng, et al.
Published: (2023-03-01)

Andrographolide Attenuates Established Pulmonary Hypertension via Rescue of Vascular Remodeling
by: Xiaowei Nie, et al.
Published: (2021-11-01)

Updated perspective of EPAS1 and the role in pulmonary hypertension
by: Na Wang, et al.
Published: (2023-02-01)

Emerging Epigenetic Targets and Their Molecular Impact on Vascular Remodeling in Pulmonary Hypertension
by: A. Dushani C. U. Ranasinghe, et al.
Published: (2024-01-01)

The Emerging Therapeutic Role of Prostaglandin E2 Signaling in Pulmonary Hypertension
by: Lan Ye, et al.
Published: (2023-11-01)

Novel hub genes associated with pulmonary artery remodeling in pulmonary hypertension
by: Rubin Tan, et al.
Published: (2022-11-01)

Macrophage depletion protects against endothelial dysfunction and cardiac remodeling in angiotensin II hypertensive mice
by: Yuantong Tian, et al.
Published: (2021-11-01)

Dapagliflozin has No Protective Effect on Experimental Pulmonary Arterial Hypertension and Pulmonary Trunk Banding Rat Models
by: Huayang Li, et al.
Published: (2021-11-01)

The Role and Mechanism of Gut Microbiota in Pulmonary Arterial Hypertension
by: Yi-Hang Chen, et al.
Published: (2022-10-01)

Mitochondrial Dysfunction in Pulmonary Hypertension
by: Gusty Rizky Teguh Ryanto, et al.
Published: (2023-02-01)

Optimization of resting tension for wire myography in male rat pulmonary arteries
by: Rira Choi, et al.
Published: (2024-01-01)

Hydrogen Sulfide Metabolism and Pulmonary Hypertension
by: Lukas Roubenne, et al.
Published: (2021-06-01)

Transcription factors and potential therapeutic targets for pulmonary hypertension
by: Liu Yang, et al.
Published: (2023-03-01)

Conditioned medium from M2b macrophages modulates the proliferation, migration, and apoptosis of pulmonary artery smooth muscle cells by deregulating the PI3K/Akt/FoxO3a pathway
by: Suiqing Huang, et al.
Published: (2020-05-01)

The Short-Chain Fatty Acid Butyrate Attenuates Pulmonary Vascular Remodeling and Inflammation in Hypoxia-Induced Pulmonary Hypertension
by: Vijaya Karoor, et al.
Published: (2021-09-01)

CircALMS1 Alleviates Pulmonary Microvascular Endothelial Cell Dysfunction in Pulmonary Hypertension
by: Xiaoyi Hu, et al.
Published: (2024-03-01)

Biomechanical and Mechanobiological Drivers of the Transition From PostCapillary Pulmonary Hypertension to Combined Pre−/PostCapillary Pulmonary Hypertension
by: Betty J. Allen, et al.
Published: (2023-02-01)

Role of Long Non-Coding RNAs in Pulmonary Arterial Hypertension
by: Yun Han, et al.
Published: (2021-07-01)

Serum Liberation of Fetal Fibronectin Variants in Patients with Pulmonary Hypertension: ED-A<sup>+</sup> Fn as Promising Novel Biomarker of Pulmonary Vascular and Right Ventricular Myocardial Remodeling
by: Laura Bäz, et al.
Published: (2021-06-01)

Advances in the research of sulfur dioxide and pulmonary hypertension
by: Xin Liu, et al.
Published: (2023-10-01)

Strategies of Macrophages to Maintain Bone Homeostasis and Promote Bone Repair: A Narrative Review
by: Yingkun Hu, et al.
Published: (2022-12-01)

Arterial remodeling in older patients with arterial hypertension
by: A. V. Agafonov, et al.
Published: (2005-06-01)

The Platelet-Derived Growth Factor Pathway in Pulmonary Arterial Hypertension: Still an Interesting Target?
by: Julien Solinc, et al.
Published: (2022-04-01)

Neurotrophins in the pathogenesis of pulmonary hypertension and right ventricular dysfunction
by: E. M. Andreeva, et al.
Published: (2022-03-01)

Tumor−associated macrophage polarization in the inflammatory tumor microenvironment
by: Zijuan Zou, et al.
Published: (2023-02-01)

Light at the ENDothelium-role of Sox17 and Runx1 in endothelial dysfunction and pulmonary arterial hypertension
by: Robert Simmons Beck, et al.
Published: (2023-11-01)

Progress in Pulmonary Vein Stenosis: Lessons from Success in Treating Pulmonary Arterial Hypertension
by: Kathy J. Jenkins, et al.
Published: (2022-05-01)